Cancer and cell biology experts have developed a new mass spectrometry-based tool which provides more precise, cost-effective data collection for drug discovery efforts.
The fresh results from clinical trials 2009 H1N1 Influenza Vaccines In Healthy Adults indicate that this vaccines are well tolerated and induce a strong immune response. The trials are an important part of the ongoing worldwide effort to develop vaccines to protect the public from 2009 H1N1 influenza.
